Last Price | 10.05 | Max Price | 11.65 |
Min Price | 9.70 | 1 Year return | -6.94 |
Sector | Health Care | Subsector | Health Care Eq. & Services |
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 151 | 2,019,579 | 0.01 % |
2020 | 147 | 2,170,517 | 0.01 % |
2021 | 169 | 2,404,876 | 0.01 % |
2022 | 197 | 2,645,792 | 0.01 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
No Records Found
No Records Found
Over the period from December 2015 till December 2016 the stock lost around 0 percent. Prim' stock rose the past 5 years at around 148 percent. Prim's revenues between 2011 and 2015 were quite similar and moved between 85,82 million euros and 99,23 million euros. Prim's net incomes between 2011 and 2015 were quiet stable and moved between 8,91 million euros and 10,7 million euros.
Between 2006 and 2016 the global health care companies gained around 102 percent. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-December 2016) there is a plus of 102 percent.
The Spanish company paid out dividends in the past 5 years. On average Prim's dividend yield over the past 5 years was around 1,49 percent annually.
At the end of 2015 the Spanish company had a balance sheet of around 116,21 million euros. Of the total balance sheet 23,96 million euros (20,62 percent) was financed by debt.
At the end of 2015 around 17,16 million stocks were listed.
All Prim's financial reports are available here. More information about Prim can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
99
|
110
|
121
|
134
|
151
|
147
|
Costs |
89
|
97
|
107
|
120
|
140
|
140
|
Profit |
11
|
13
|
14
|
14
|
11
|
7
|
Margin of profit |
10.78
|
11.90
|
11.46
|
10.50
|
7.43
|
4.70
|
ROI |
11.60
|
12.99
|
13.10
|
12.97
|
10.10
|
6.19
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
92
|
101
|
106
|
109
|
111
|
112
|
Debt |
24
|
27
|
32
|
29
|
39
|
52
|
Total assets |
116
|
128
|
138
|
138
|
150
|
164
|
Solvency |
79.38
|
78.60
|
76.99
|
78.69
|
74.20
|
68.28
|
Cash |
19
|
21
|
25
|
18
|
12
|
36
|
Cashflow |
10
|
10
|
11
|
7
|
-1
|
25
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
0.44
|
0.38
|
0.34
|
0.22
|
-0.02
|
0.48
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
9.01
|
8.90
|
10.50
|
10.45
|
11.60
|
Eps |
0.78
|
0.80
|
0.81
|
0.65
|
0.40
|
Price/earnings-ratio |
11.55
|
11.12
|
12.96
|
16.08
|
25.12
|
Dividend |
0.46
|
0.58
|
0.58
|
0.33
|
0.31
|
Dividend % |
5.11 %
|
6.52 %
|
5.52 %
|
3.16 %
|
3.08 %
|
Payout % |
0.59
|
0.72
|
0.72
|
0.51
|
0.78
|
Book value |
5.82
|
6.12
|
6.28
|
6.41
|
6.45
|
Market to book |
0.65
|
0.69
|
0.60
|
0.61
|
0.64
|
Cashflow per stock |
0.60
|
0.63
|
0.38
|
-0.04
|
1.44
|
Stocks |
17
|
17
|
17
|
17
|
17
|
Market Cap |
156.15
|
154.21
|
181.93
|
181.06
|
174.08
|
Date
|
Price
|
---|---|
29 Nov 2024
|
10.05
|
27 Nov 2024
|
9.98
|
13 Nov 2024
|
9.70
|
08 Nov 2024
|
9.72
|
05 Nov 2024
|
9.80
|
31 Oct 2024
|
9.94
|
29 Oct 2024
|
9.82
|
23 Oct 2024
|
9.90
|
19 Oct 2024
|
9.94
|
16 Oct 2024
|
10.15
|
14 Oct 2024
|
9.96
|
05 Oct 2024
|
10.00
|
02 Oct 2024
|
10.10
|
27 Sep 2024
|
10.45
|
20 Sep 2024
|
10.80
|
17 Sep 2024
|
10.75
|
13 Sep 2024
|
10.75
|
28 Aug 2024
|
10.95
|
26 Aug 2024
|
11.00
|
23 Aug 2024
|
10.95
|
11 Aug 2024
|
10.95
|
07 Aug 2024
|
10.85
|
05 Aug 2024
|
10.70
|
01 Aug 2024
|
10.85
|
30 Jul 2024
|
11.00
|
26 Jul 2024
|
10.80
|
23 Jul 2024
|
11.65
|
16 Jul 2024
|
11.35
|
10 Jul 2024
|
10.50
|
09 Jul 2024
|
10.50
|